Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Neurocrine Bioscience | 23 | 0 | 3 | 0 | €127.05 | €137.63 | 8.331% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €10.87 | €22.78 | 109.621% |
| Ultragenyx Pharmaceutical Inc. | 16 | 1 | 3 | 0 | €41.40 | €82.93 | 100.317% |
| United Therapeutics | 15 | 0 | 0 | 0 | €220.00 | €289.92 | 31.782% |
| Exelixis Inc. | 15 | 0 | 0 | 0 | €21.94 | €26.01 | 18.534% |
| Halozyme Therapeutics Inc. | 12 | 0 | 1 | 0 | €36.53 | €54.21 | 48.398% |
| Repligen Corp. | 12 | 0 | 0 | 0 | €154.50 | €182.96 | 18.421% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €212.30 | €247.61 | 16.631% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €363.30 | €421.61 | 16.049% |
| Xencor Inc. | 9 | 1 | 1 | 0 | €18.70 | €31.74 | 69.727% |
| Agios Pharmaceuticals Inc. | 5 | 0 | 2 | 0 | €29.60 | €38.99 | 31.718% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.26 | €55.00 | 5.243% |
| Nektar Therapeutics | 3 | 1 | 1 | 0 | €1.23 | €3.70 | 201.058% |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €86.92 | - | - |